GFM
TMDX icon

GF Fund Management’s Transmedics TMDX Stock Holding History

GF Fund Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,894
Closed -$2.93M – 681
2025
Q2 		$2.93M Sell
21,894
-1,141
-5% -$125K 0.06% 170
2025
Q1 		$1.55M Hold
23,035
– – 0.04% 186
2024
Q4 		$1.44M Buy
+23,035
New +$2.14M 0.03% 187

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GF Fund Management's TMDX Position: Q3 2025 in Review

GF Fund Management sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 21,894 shares — an estimated $2.93M sold.

GF Fund Management first reported a position in TMDX in Q4 2024 and held it in 3 quarters. The position peaked at $2.93M in Q2 2025. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • GF Fund Management reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • GF Fund Management sold 21,894 Transmedics shares in Q3 2025, an estimated $2.93M.
  • GF Fund Management first reported a position in Transmedics in Q4 2024 and held it in 3 quarters.
  • GF Fund Management's Transmedics position peaked at $2.93M in Q2 2025.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.